Biomed Israel 2026 Preliminary Program
Ruti Alon, Founder and CEO, Medstrada
Ora Dar, PhD, Senior Expert, Medical Sciences and Health Innovation
Dr. Nissim Darvish, MD, PhD, Managing General Partner, Eliraz Ventures
Francois Maisonrouge, Senior Managing Director, Evercore Partners | A Turning Point in Life Sciences? What is Real? What is Not? What is Here to Stay?
Prof. Yifat Merbl, Professor of Immunology, Weizmann Institute of Science
Dr. Jeremy M. Levin, MD, Chairperson, Ovid Therapeutics and Opthea | Biotech in the Balance: Strategic Choices in a Multipolar World
HALL A
Beyond Bones and Screws: Rethinking Orthopedic Repair
Moderators
Dr. Adam L. Wollowick, MD, MBA, Advisor and Founder, Precision Life Sciences Partners
Dr. Assaf Dekel, MD, Chairman & CEO, OTS Medical
Keynote
Dr. Adam L. Wollowick, MD, MBA, Advisor and Founder, Precision Life Sciences Partners, Drivers of Value Creation in Recent Orthopaedic Transactions
HALL B
From Detection to Prediction: Diagnosing Disease Before Symptoms
Moderator
Yaron Daniely, PhD, General Partner, aMoon Fund
HALL C
The Future of Aging: Where Longevity Meets Innovation
Moderators
Prof. Varda Shalev, MD, MPA, Managing Partner, Team8 Health
Dr. Pablo Cabral, MD, Executive Director, External Innovation, Eli Lilly
HALL A
The Device is No Longer a Device: Convergence in Medical Technology
Moderators
Eyal Lifschitz, Co-Founder & Managing General Partner, Peregrine Ventures
Dr. Irit Yaniv, MD, Founding Partner and CEO, Almeda Ventures
HALL B
Reinventing Clinical Trials: New Models, Technologies and Companies
Moderator
Ittai Harel, Managing Partner, Pitango Venture Capital
HALL C
The Next Pandemic: Are We Ready? Innovation in Infectious Diseases
Moderator
Moshik Cohen-Kutner, PhD, Co-Founder and CEO, Omnix Medical
HALL D
15:30 – 16:30
Managing Cancer in an Era of Choice: Optimizing Outcomes
| Plenary Investors Panel: Biotech Investing in a New Reality: What Gets Funded, What Doesn’t, and Why?
Moderator
Mati Gill, CEO, AION Labs
Panelists
Dr. Adam Koppel, MD, PhD, Partner, Bain Capital Life Sciences
Michael Gladstone, Partner, Atlas Venture
Edward Kliphuis, Partner, Sofinnova Partners
Laura Lande-Diner, PhD, Managing Partner, Jefferson Life Sciences
Prof. Itzhak Fried, MD, Professor of Neurosurgery and Head of Applied Brain Research Center, UCLA & the Reichman University | The Brain at a Turning Point: Repair, Decode, and Reimagine
Dror Bin, CEO, Israel Innovation Authority
HALL A
Beyond NeuroPharma and NeuroTech: Integrated Brain Control
Moderators
Iris Grossman, PhD, Chief Therapeutics Officer, Eleven Therapeutics
Prof. Itzhak Fried, MD, Professor of Neurosurgery and Head of Applied Brain Research Center, UCLA & the Reichman University
Company Presenters
Elisabeth Kogan, CEO & Co-Founder, Syremis Therapeutics
HALL B
When Biology Becomes a Language: BioData Teaching
Moderator
Shai Melcer, PhD, Head of Bio-Convergence, Israel Innovation Authority
HALL C
Rewriting Biology in Vivo: The Age of Cellular Reprogramming – The Next Frontiers in Genetic Medicine
Moderator
Christian Dombrowski, PhD, Senior Vice President, Averna Therapeutics
Keynote
Michelle Lynn-Hall, PhD, Co-Founder and General Partner, Entrée Bioventures
HALL A
Engineering the Beating System: Biology Meets Technology
Moderators
Prof. Chaim Lotan, MD, Director, Heart Institute, Chief Innovation Officer, Hadassah, Hebrew University
Gilad Glick, Vice President, Venture Investments, MedTech, JJDC
HALL B
How AI Is Rewiring Pharma R&D: From Molecules to Models to Quantum Technology
Moderators
Dr. Karin Noy, PhD, External Science Lead AI Discovery & Early Development, Pfizer
Yael Gruenbaum-Cohen, DMD, PhD, General Partner, Entree Bioventure
HALL C
Redefining the Fight Against Cancer: New Targets, New Modalities
Moderator
Prof. Amnon Peled, Director of the Gene Therapy Institute, Hadassah – Hebrew University Medical Center
Keynotes
Prof. Gal Merkel, MD, PhD, MBA, Director, The Davidoff Cancer Center, Founder & Chairmen, Samueli Cancer Institute, Deputy CEO, Rabin Medical Center, Professor, Faculty of Medicine, Tel Aviv University
Michael A. Margolis, R.Ph., Senior Managing Director, Head of Healthcare Investment Banking, Oppenheimer & Co. Inc.
HALL D
15:30 – 16:30
Gene Editing in Plants: CRISPR and Beyond
Moderator
Dror Shalitin, Founder and CEO, PlantArcBio
Keynote
Dan SungDongYul , PhD, Executive Vice President, Seed Research & Business Division, ToolGen
AI and the Future of Medicine: What Will Truly Change – and What Will not
Dr. Boaz Hirshberg, MD, Senior Vice President, Clinical Sciences, Internal Medicine, Regeneron
Philip Nelson, Director, Software Engineering, Google Research
Genomics Meets AI: From Data to Decisions
Ariel Larey, AI Research Scientist, NVIDIA
Prof. Gideon Rechavi, MD PhD, Founding Director, Cancer Research Center, Sheba Medical Center, Professor of Pediatrics and Human Molecular Genetics, Tel Aviv University
Prof. Dror Harats, MD, CEO, ImmuneWalk Therapeutics
HALL A
Restoring Vision: Where Biology Meets Engineering
Moderator
Prof. Anat Loewenstein, MD, President of the Israeli Ophthalmological Society, Dean of the Faculty of Medicine, Chairperson of Ophthalmology, Tel Aviv University, Sourasky Medical Center
Dr. Barak Azmon, MD, Director, Pres-By
Dr. Jonathan Weyne, MD, Vice President Ophthalmology Therapeutic, Regeneron
Prof. Itay Chowers, MD, Professor of Ophthalmology & Chairman at the Division of Ophthalmology, Hadassah – Hebrew University Medical Center
Keynote
Dr. Jonathan Weyne, MD, Vice President Ophthalmology Therapeutic, Regeneron
HALL B
AI as an Equalizer: From Center to Periphery in Healthcare
Moderator
Avner Halperin, CEO, Sheba Impact
HALL C
Shaping the Future of Personalized Nutrition: Evidence-Driven Science Meets Real-World
Moderator
Tammy Meiron, PhD, CTO, Fresh Start FoodTech Incubator
